Alexion Pharmaceuticals
$108.779876543210-$,.9876543210-$,.9876543210-$,.9876543210-$,.9876543210-$,.9876543210-$,.9876543210-$,.9876543210-$,.
$108.77
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
+$2.48 (+2.34%) Today
+$0.40 (+0.37%) As of 6:00 PM EST after-hours
Why Robinhood?
You can buy or sell ALXN and other stocks, options, ETFs, and crypto commission-free!
About ALXN
Alexion Pharmaceuticals, Inc. Common Stock, also called Alexion Pharmaceuticals, is a biopharmaceutical company, which focuses on serving patients with devastating and ultra-rare disorders through the development and commercialization of life-transforming therapeutic products. Read More Its products include ultomiris, soliris, strensiq and kanuma. The company was founded by Joseph A. Madri, David W. Keiser, Stephen P. Squinto and Leonard Bell in January 1992 and is headquartered in Boston, MA.
Employees
2,656
Headquarters
Boston, Massachusetts
Founded
1992
Market Cap
23.98B
Price-Earnings Ratio
16.61
Dividend Yield
0.00
Average Volume
1.45M
High Today
$108.59
Low Today
$106.02
Open Price
$106.79
Volume
1.75M
52 Week High
$141.86
52 Week Low
$92.56
Collections
Analyst Ratings
82%
of 22 ratings
Buy
82%
Hold
18%
Sell
0%
ALXN Earnings
$1.49
$1.92
$2.36
$2.79
Q1 2018
Q2 2018
Q3 2018
Q4 2018
Q1 2019
Q2 2019
Q3 2019
Q4 2019
Estimated
—
Actual
Expected Feb 3, Pre-Market